Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle (Q33351113)

26 July 2017

1 reference

title

Getting personal with prostate cancer: adding new pieces to an incomplete jigsaw puzzle (English)

1 reference

https://api.crossref.org/works/10.1159/000327723

26 July 2017

Getting Personal with Prostate Cancer: Adding New Pieces to an Incomplete Jigsaw Puzzle (English)

1 reference

neoplastic gene expression regulation

1 December 2024

main subject

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21540577

1 December 2024

Ammad A. Farooqi

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21540577

1 December 2024

Shahzad Bhatti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A21540577

1 December 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=21540577

1 December 2024

publication date

30 April 2011

1 reference

26 July 2017

published in

Urologia Internationalis

1 reference

26 July 2017

1 reference

26 July 2017

1 reference

26 July 2017

page(s)

127-133

1 reference

ETS gene fusions in prostate cancer

26 July 2017

cites work

1 reference

Intragenic Rearrangement and Altered RNA Splicing of the Androgen Receptor in a Cell-Based Model of Prostate Cancer Progression

21 January 2018

1 reference

Splicing of a novel androgen receptor exon generates a constitutively active androgen receptor that mediates prostate cancer therapy resistance

21 January 2018

1 reference

Identification of novel truncated androgen receptor (AR) mutants including unreported pre-mRNA splicing variants in the 22Rv1 hormone-refractory prostate cancer (PCa) cell line.

21 January 2018

1 reference

A novel androgen receptor splice variant is up-regulated during prostate cancer progression and promotes androgen depletion-resistant growth

21 January 2018

1 reference

Castration resistance in human prostate cancer is conferred by a frequently occurring androgen receptor splice variant

21 January 2018

1 reference

Arachidonic acid pathway members PLA2G7, HPGD, EPHX2, and CYP4F8 identified as putative novel therapeutic targets in prostate cancer

21 January 2018

1 reference

HOXB13 is co-localized with androgen receptor to suppress androgen-stimulated prostate-specific antigen expression

21 January 2018

1 reference

Transcription Factor Stat5 Knockdown Enhances Androgen Receptor Degradation and Delays Castration-Resistant Prostate Cancer Progression In vivo

21 January 2018

1 reference

BTG2 is an LXXLL-dependent co-repressor for androgen receptor transcriptional activity

21 January 2018

1 reference

GLI1, a crucial mediator of sonic hedgehog signaling in prostate cancer, functions as a negative modulator for androgen receptor.

21 January 2018

1 reference

GRP78 up-regulation is associated with androgen receptor status, Hsp70-Hsp90 client proteins and castrate-resistant prostate cancer

21 January 2018

1 reference

Pharmacological targeting of constitutively active truncated androgen receptor by nigericin and suppression of hormone-refractory prostate cancer cell growth.

21 January 2018

1 reference

MicroRNA-34 mediates AR-dependent p53-induced apoptosis in prostate cancer

21 January 2018

1 reference

Grape Seed Extract Regulates Androgen Receptor-Mediated Transcription in Prostate Cancer Cells Through Potent Anti–Histone Acetyltransferase Activity

21 January 2018

1 reference

Procyanidin B3, an inhibitor of histone acetyltransferase, enhances the action of antagonist for prostate cancer cells via inhibition of p300-dependent acetylation of androgen receptor.

21 January 2018

1 reference

Targeted inhibition of mitochondrial Hsp90 suppresses localised and metastatic prostate cancer growth in a genetic mouse model of disease.

21 January 2018

1 reference

Antitumour activity of MDV3100 in castration-resistant prostate cancer: a phase 1-2 study

21 January 2018

1 reference

KN-93 inhibits androgen receptor activity and induces cell death irrespective of p53 and Akt status in prostate cancer

21 January 2018

1 reference

Green tea polyphenol EGCG sensitizes human prostate carcinoma LNCaP cells to TRAIL-mediated apoptosis and synergistically inhibits biomarkers associated with angiogenesis and metastasis

21 January 2018

1 reference

Sulforaphane enhances the therapeutic potential of TRAIL in prostate cancer orthotopic model through regulation of apoptosis, metastasis, and angiogenesis

21 January 2018

1 reference

Therapeutic efficacy of curcumin/TRAIL combination regimen for hormone-refractory prostate cancer

21 January 2018

1 reference

ATM kinase activity modulates cFLIP protein levels: potential interplay between DNA damage signalling and TRAIL-induced apoptosis

21 January 2018

1 reference

Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells

21 January 2018

1 reference

miR-34a repression of SIRT1 regulates apoptosis

21 January 2018

1 reference

MiR-34, SIRT1 and p53: the feedback loop

21 January 2018

1 reference

Involvement of microRNA-21 in mediating chemo-resistance to docetaxel in androgen-independent prostate cancer PC3 cells

21 January 2018

1 reference

miR-148a is an androgen-responsive microRNA that promotes LNCaP prostate cell growth by repressing its target CAND1 expression

21 January 2018

1 reference

The functional significance of microRNA-145 in prostate cancer

21 January 2018

1 reference

Targeting Notch signalling by the conserved miR-8/200 microRNA family in development and cancer cells

21 January 2018

1 reference

miR-99 family of MicroRNAs suppresses the expression of prostate-specific antigen and prostate cancer cell proliferation

21 January 2018

1 reference

miR-17* Suppresses Tumorigenicity of Prostate Cancer by Inhibiting Mitochondrial Antioxidant Enzymes

21 January 2018

1 reference

miR-143 decreases prostate cancer cells proliferation and migration and enhances their sensitivity to docetaxel through suppression of KRAS

21 January 2018

1 reference

MicroRNA-100 expression is independently related to biochemical recurrence of prostate cancer.

21 January 2018

1 reference

Discovery pipeline for epigenetically deregulated miRNAs in cancer: integration of primary miRNA transcription

21 January 2018

1 reference

The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44

21 January 2018

1 reference

Green tea polyphenol EGCG blunts androgen receptor function in prostate cancer

21 January 2018

1 reference

Tumour-initiating stem-like cells in human prostate cancer exhibit increased NF-κB signalling

21 January 2018

1 reference

Hedgehog overexpression leads to the formation of prostate cancer stem cells with metastatic property irrespective of androgen receptor expression in the mouse model

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1159/000327723

1 reference

26 July 2017

1 reference